Zoetis Inc (NYSE:ZTS) – Investment analysts at Jefferies Group lifted their FY2018 earnings per share estimates for shares of Zoetis in a report issued on Tuesday. Jefferies Group analyst J. Holford now forecasts that the company will post earnings of $3.11 per share for the year, up from their prior estimate of $2.79. Jefferies Group has a “Buy” rating and a $89.00 price objective on the stock. Jefferies Group also issued estimates for Zoetis’ FY2022 earnings at $4.93 EPS.
A number of other equities analysts have also recently commented on ZTS. Piper Jaffray Companies reiterated a “buy” rating and issued a $86.00 target price on shares of Zoetis in a report on Thursday. Cantor Fitzgerald set a $85.00 target price on Zoetis and gave the stock a “buy” rating in a report on Thursday, January 11th. Citigroup upgraded Zoetis from a “neutral” rating to a “buy” rating and set a $85.00 target price for the company in a report on Thursday, January 4th. BMO Capital Markets reiterated a “hold” rating on shares of Zoetis in a report on Monday, January 8th. Finally, BidaskClub cut Zoetis from a “strong-buy” rating to a “buy” rating in a report on Wednesday, September 20th. Two analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have issued a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $73.72.
Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, November 2nd. The company reported $0.65 EPS for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.02. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.32 billion. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. The company’s quarterly revenue was up 8.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.52 EPS.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Investors of record on Friday, January 19th will be issued a dividend of $0.126 per share. The ex-dividend date of this dividend is Thursday, January 18th. This represents a $0.50 dividend on an annualized basis and a yield of 0.66%. This is a boost from Zoetis’s previous quarterly dividend of $0.11. Zoetis’s payout ratio is presently 22.11%.
A number of institutional investors and hedge funds have recently bought and sold shares of ZTS. Northwestern Mutual Wealth Management Co. boosted its holdings in Zoetis by 16.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock valued at $100,000 after acquiring an additional 230 shares during the period. Steward Partners Investment Advisory LLC purchased a new position in Zoetis during the 3rd quarter valued at $114,000. Harfst & Associates Inc. boosted its holdings in Zoetis by 16.1% during the 2nd quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock valued at $117,000 after acquiring an additional 260 shares during the period. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its holdings in Zoetis by 251.9% during the 3rd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock valued at $121,000 after acquiring an additional 1,360 shares during the period. Finally, Shine Investment Advisory Services Inc. boosted its holdings in Zoetis by 86.5% during the 3rd quarter. Shine Investment Advisory Services Inc. now owns 2,242 shares of the company’s stock valued at $143,000 after acquiring an additional 1,040 shares during the period. Institutional investors own 93.14% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Jefferies Group Analysts Raise Earnings Estimates for Zoetis Inc (ZTS)” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://www.com-unik.info/2018/01/18/jefferies-group-analysts-raise-earnings-estimates-for-zoetis-inc-zts.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.